Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms.
Krause
Matthew P
MP
Dept of Pathology & Molecular Medicine, McMaster University, 1200 Main St., W. Hamilton, ON, Canada L8N 3Z5.
Riddell
Michael C
MC
Hawke
Thomas J
TJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006943:Hyperglycemia / Q000503:physiopathology; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D015850:Interleukin-6 / Q000097:blood; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000502:physiology; D018485:Muscle Fibers, Skeletal / Q000473:pathology; D009124:Muscle Proteins / Q000187:drug effects / Q000502:physiology; D018482:Muscle, Skeletal / Q000502:physiology / Q000503:physiopathology*; D009133:Muscular Atrophy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D010101:Oxygen Consumption; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D012038:Regeneration; D014938:Work Capacity Evaluation
D001786:Blood Glucose; D015850:Interleukin-6; D009124:Muscle Proteins; D017395:Plasminogen Activator Inhibitor 1; D007334:Insulin-Like Growth Factor I; D006854:Hydrocortisone